|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.47 USD | -0.66% |
|
-2.62% | -16.48% |
| 02:45pm | BMO Capital Adjusts Price Target on Incyte to $56 From $64 | MT |
| Apr. 01 | Incyte, China Medical System Sign Collaboration, License Agreement | MT |
2
Attachments
Disclaimer
Incyte Corporation published this content on 22 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 October 2021 13:03:04 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.48% | 11.86B | |
| -5.99% | 84.46B | |
| +2.76% | 40.85B | |
| -25.50% | 27.69B | |
| +53.61% | 24.28B | |
| -7.70% | 17.09B | |
| -33.74% | 13.67B | |
| -11.19% | 11.79B | |
| -2.25% | 8.07B | |
| +2.35% | 7.51B |
INCYTE CORPORATION 
